Impact of chronic toxoplasmosis in pregnancy: association between maternal seropositivity for Toxoplasma gondii IgG antibodies and fetal growth restriction

Parasitol Res. 2023 Dec 11;123(1):25. doi: 10.1007/s00436-023-08068-y.

Abstract

Insults caused by acute infections during the gestational period on fetal development are known; however, new evidence suggests that chronic infectious diseases can also impact the maternal immune status and lead to negative consequences for the neonate. This study investigated the association between the prevalence of specific antibodies in pregnant women and alterations in fetal development at birth. A follow-up study evaluated women during the gestational period and their respective newborns at delivery time. The pregnant women were tested for the presence of antibodies to infectious agents: Toxoplasma gondii (T. gondii), cytomegalovirus (CMV), syphilis, human immunodeficiency virus (HIV), hepatitis B and C. Semi-structured questionnaires were administered to the pregnant women at the time of recruitment after obtaining informed consent. Detailed information about the newborns was extracted from medical records. The seroprevalence of chronic T. gondii infection, as determined by the presence of IgG antibodies against the protozoan, was found to be 56.2%, while the overall prevalence of CMV IgG antibodies was 96.3%. Non-primiparous pregnant women from socio-economic classes, less affluent groups, and skilled working-class individuals had higher chances of testing positive for specific T. gondii IgG antibodies. Newborns classified as small for gestational age represented 12.9% of the total. Those born to mothers seropositive for anti-T. gondii IgG antibodies were 9.4 times more likely to be born small for gestational age (p = 0.035). The results suggest that chronic T. gondii infection may contribute to higher rates of newborns with growth restriction. These findings add to a growing body of evidence regarding the impact of chronic infectious diseases on intrauterine fetal development.

Keywords: Birth cohort; Pregnancy; Serology; Small for gestational age; Toxoplasmosis.

MeSH terms

  • Antibodies, Protozoan
  • Cytomegalovirus Infections* / complications
  • Cytomegalovirus Infections* / epidemiology
  • Female
  • Fetal Growth Retardation / epidemiology
  • Follow-Up Studies
  • Hepatitis B*
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Infant, Newborn
  • Pregnancy
  • Risk Factors
  • Seroepidemiologic Studies
  • Toxoplasma*
  • Toxoplasmosis* / epidemiology

Substances

  • Immunoglobulin M
  • Antibodies, Protozoan
  • Immunoglobulin G